3Tersteeg C,De Maat S,De Meyer SF,et al.Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy[J].Circulation,2014,129:1320-1331.
4Kremer Hovinga JA,Lammle B.Role of ADAMTS13in the pathogenesis,diagnosis,and treatment of thrombotic thrombocytopenic purpura[J].Hematology Am Soc Hematol Educ Program,2012,2012:610-616.
5Pos W,Luken BM,Sorvillo N,et al.Humoral immune response to ADAMTS13 in acquired thrombotic thrombocytopenic purpura[J].J Thromb Haemost,2011,9:1285-1291.
6Kremer Hovinga JA,Vesely SK,Terrell DR,et al.Survival and relapse in patients with thrombotic thrombocytopenic purpura[J].Blood,2010,115:1500-1511;quiz 1662.
7George JN.How I treat patients with thrombotic thrombocytopenic purpura:2010[J].Blood,2010,116:4060-4069.
8Jacob S,Dunn BL,Qureshi ZP,et al.Ticlopidine-,clopidogrel-,and prasugrel-associated thrombotic thrombocytopenic purpura:a 20-year review from the Southern Network on Adverse Reactions(SONAR)[J].Semin Thromb Hemost,2012,38:845-853.
9Coppo P,Busson M,Veyradier A,et al.HLA-DRB1*11:a strong risk factor for acquired severe ADAMTS13 deficiency-related idiopathic thrombotic thrombocytopenic purpura in Caucasians[J].J Thromb Haemost,2010,8:856-859.
10Scully M,Brown J,Patel R,et al.Human leukocyte antigen association in idiopathic thrombotic thrombocytopenic purpura:evidence for an immunogenetic link[J].J Thromb Haemost,2010,8:257-262.
